45963-0614 Irinotecan Hydrochloride

Product NDC:

45963-0614

Brand Name:

Irinotecan Hydrochloride

Generic Name:

Irinotecan Hydrochloride

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Substances:

Name: Irinotecan Hydrochloride

Strength: 20.0

Unit: mg/mL

Packages:

Code: 45963-0614-51

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-51) / 2 mL in 1 VIAL, SINGLE-DOSE

Effective Date: March 12, 2015

Discontinued:

Code: 45963-0614-55

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-55) / 5 mL in 1 VIAL, SINGLE-DOSE

Effective Date: March 12, 2015

Discontinued:

Code: 45963-0614-56

Description:

Effective Date:

Discontinued: Aug. 11, 2018

Code: 45963-0614-81

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-81) > 2 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Jan. 17, 2019

Discontinued: Jan. 1, 2023

Code: 45963-0614-85

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-85) / 5 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Aug. 10, 2018

Discontinued: June 30, 2023

SEER*Rx Category:

Chemotherapy

Major Class:

Topoisomerase I Inhibitor

Minor Class:

Camptothecin Analogs

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox